Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02774265 · ClinicalTrials.gov registry record · Phase 3
A Different Approach to Preventing Thrombosis
A Phase 3 study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- Phase 3
- Development phase
- 329
- Enrollment target
NCT02774265 is a Phase 3 study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 329 participants.
The verdict
NCT02774265, a Phase 3 study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 329 participants
- Enrollment target
Study Summary
The purpose of this study is to perform a pragmatic randomized controlled trial to compare the use of low molecular weight heparin (LMWH, lovenox, enoxaparin) versus acetylsalicylic acid (ASA) for venous thromboembolism (VTE) prophylaxis in patients with high-risk lower extremity fractures.
Interventions
- DRUG VTE prophylaxis with Enoxaparin 30mg BID
- DRUG VTE prophylaxis with Aspirin 81mg BID
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 329 participants |
| Start Date | 2016-01 |
| Est. Completion | 2017-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02774265
The ClinicalTrials.gov registry entry for NCT02774265 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 329 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which VTE prophylaxis with Enoxaparin 30mg BID is the first listed.
NCT02774265 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02774265 about?
NCT02774265 is a clinical study titled "A Different Approach to Preventing Thrombosis". The purpose of this study is to perform a pragmatic randomized controlled trial to compare the use of low molecular weight heparin (LMWH, lovenox, enoxaparin) versus acetylsalicylic acid (ASA) for venous thromboembolism (VTE) prophylaxis in patients with high-risk lower extremity fractures.
What is the current status of trial NCT02774265?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 329 participants. The study started on 2016-01. Estimated completion is 2017-09.
What interventions are being tested in trial NCT02774265?
The interventions under investigation include: VTE prophylaxis with Enoxaparin 30mg BID (DRUG), VTE prophylaxis with Aspirin 81mg BID (DRUG).
Who is sponsoring clinical trial NCT02774265?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.